This highly effective, FDA-approved weight management solution belongs to a class of medications known as GLP-1 receptor agonists, which mimic the bodys naturally occurring glucagon-like peptide-1 hormone
The study found that a prescription for Ozempic and other drugs containing the active compound, semaglutide, was associated with an increased risk of NAION, or nonarteritic anterior ischemic optic neuropathy
The most realistic timeline places FDA approval in late next year, with commercial launch projected for early the year after
Patients on the highest dose lost close to a third of their body weight over around 18 months , a level of weight reduction that until now has typically only been seen with surgery
The orally disintegrating tablet formulation requires specific storage conditions to preserve both the integrity of the active ingredients and the unique characteristics that allow for rapid dissolution in the oral cavity